Amplicon-dependent expression of CCNE1, together with the genes POP4, PLEKHF1, C19orf12 and C19orf2 that flank CCNE1 on this segment, was linked with primary treatment failure in ovarian cancer, possibly due to rapid repopulation of the tumor after chemotherapy [31]. The gene discussed is C19orf12; the disease is ovarian carcinoma.